emtricitabine

Italy

Drugs containing this active substance

  • BIKTARVY

    Biktarvy is used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, adolescents, and children (aged 2 years and older and weighing at least 14 kg). The drug reduces the amount of HIV in the body, strengthens the immune system, and reduces the risk of illnesses related to the infection.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    bictegravir -
    tenofovir alafenamide -

    ATC: J05AR20

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • It is used, in combination with other medicines, for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg. The drug helps to reduce the amount of virus in the body.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • It is used for the treatment of human immunodeficiency virus (HIV) infection in adults aged 18 years and older who have previously been treated with other antiretroviral medicines and who have had an HIV-1 infection under control for at least three months.

    Form: tablets, film-coated

    Active substance Dosage
    efvavirenz -
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR06

    Manufacturer: MYLAN PHARMACEUTICALS LIMITED

  • It is used for the treatment of human immunodeficiency virus (HIV) infection in adults aged 18 years and older who have previously been treated with other antiretroviral medicines and who have had the HIV-1 infection under control for at least three months.

    Form: tablets, film-coated

    Active substance Dosage
    efvavirenz -
    emtricitabine -
    efvavirenz -
    tenofovir disoproxil -

    ATC: J05AR06

    Manufacturer: ZENTIVA K.S.

  • It is used for the treatment of human immunodeficiency virus (HIV) infection in adults aged 18 years and older who have already received other antiretroviral medicines and who have had the HIV-1 infection under control for at least three months.

    Form: tablets, film-coated

    Active substance Dosage
    efvavirenz -
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR06

    Manufacturer: KRKA D.D. NOVO MESTO

  • It is used for the treatment of human immunodeficiency virus (HIV) infection in adults over 18 years of age who have already been treated with other antiretroviral drugs and whose HIV-1 infection has been under control for at least three months.

    Form: tablets, film-coated

    Active substance Dosage
    efvavirenz -
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR06

    Manufacturer: ZENTIVA K.S.

  • This medicine is used, in combination with other medicines, for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already received other treatments that are no longer effective or have caused adverse effects. It can also be used to reduce the risk of contracting HIV in adults and adolescents (from 12 years of age and weighing at least 35 kg) if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: AEQUILIBRIUM PHARMA S.R.L.

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already received other treatments that are no longer effective or have caused adverse effects. It can also be used to reduce the risk of contracting HIV in adults and adolescents if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil fumarate -

    ATC: J05AR03

    Manufacturer: CIPLA EUROPE NV

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already received other treatments that are no longer effective. It can also be used to reduce the risk of contracting HIV in adults, if taken daily along with safe sex practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: DOC GENERICI SRL

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg) who have already received other treatments that are no longer effective or who have experienced adverse effects. It can also be used to reduce the risk of contracting HIV in adults and adolescents over 12 years of age weighing at least 35 kg, if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    tenofovir disoproxil -
    emtricitabine -

    ATC: J05AR03

    Manufacturer: TEVA ITALIA S.R.L.

  • It is an antiviral drug used for the treatment of human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 years and older weighing at least 35 kg. It is used to reduce the amount of HIV in the body, improving the immune system.

    Form: tablets, film-coated

    Active substance Dosage
    rilpivirine -
    tenofovir alafenamide -
    emtricitabine -

    ATC: J05AR19

    Manufacturer: VIATRIS LIMITED

  • It is used in combination with other medicines for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg. The drug helps to reduce the amount of virus in the body by blocking its multiplication.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: VIATRIS LIMITED

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg). It can also be used to reduce the risk of acquiring HIV-1 infection in adults and adolescents weighing at least 35 kg, if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: KRKA D.D. NOVO MESTO

  • This medicine is used for the treatment of HIV-1 infection in adults and adolescents aged between 12 and 18 years weighing at least 35 kg who have already received other treatments that are no longer effective or have caused side effects. It must always be used in combination with other HIV medicines.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: KRKA D.D. NOVO MESTO

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already received other treatments that are no longer effective or have caused adverse effects. It can also be used to reduce the risk of contracting HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    tenofovir disoproxil -
    emtricitabine -

    ATC: J05AR03

    Manufacturer: MYLAN PHARMACEUTICALS LIMITED

  • It is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already used other drugs that are no longer effective. It can also be used to reduce the risk of contracting HIV in adults and adolescents under the same conditions, if taken daily along with safe sexual practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: ZENTIVA K.S.

  • Emtriva is a treatment for Human Immunodeficiency Virus (HIV) infection in adults, children, and infants aged 4 months and older. It works by lowering the amount of HIV in the blood and can help increase the number of T cells (CD4 cells). It is not a cure for HIV and must be used in conjunction with other medicines.

    Form: solution, oral

    Active substance Dosage
    emtricitabine -

    ATC: J05AF09

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • Eviplera is a treatment for human immunodeficiency virus (HIV) infection in adults aged 18 years and older. It is used to reduce the amount of HIV in the body, improving the immune system and reducing the risk of related illnesses.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil fumarate -
    rilpivirine -

    ATC: J05AR08

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • Genvoya is used for the treatment of HIV-1 infection in adults, adolescents, and children (aged 2 years and older and weighing at least 14 kg). The drug reduces the amount of HIV in the body, improving the immune system.

    Form: tablets, film-coated

    Active substance Dosage
    elvitegravir -
    cobicistat -
    emtricitabine -
    tenofovir alafenamide fumarate -

    ATC: J05AR18

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • It is an antiviral drug used for the treatment of human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 years and older weighing at least 35 kg. It serves to reduce the amount of virus in the body, improving the immune system.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    rilpivirine -
    tenofovir alafenamide -

    ATC: J05AR19

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • Symtuza is an antiretroviral medicine used for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 40 kg. It helps to reduce the amount of HIV-1 in the body, improving immune defenses and reducing the risk of related illnesses, but it is not a cure for the infection.

    Form: tablets, film-coated

    Active substance Dosage
    darunavir -
    emtricitabine -
    cobicistat -
    tenofovir alafenamide -

    ATC: J05AR22

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.

  • Truvada is used to treat HIV-1 infection in adults and adolescents (from 12 years of age and weighing at least 35 kg) who have already received other treatments that are no longer effective or have caused adverse effects. It can also be used to reduce the risk of contracting HIV in adults and adolescents (from 12 years of age and weighing at least 35 kg) if taken daily along with safe sex practices.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir disoproxil -

    ATC: J05AR03

    Manufacturer: GILEAD SCIENCES IRELAND UC